Physician profile
Megan E Knecht
NPI 1639514680
$1,558.76
in general payments reported to CMS, 2019-2025
12 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $632 · 2023: $284 · 2024: $48.87 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $269.29 | 2024-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $235.44 | 2021-2022 | |
| Boston Scientific Corporation | $173.57 | 2022 | |
| Heartflow, INC. | $155.28 | 2022 | |
| Cvrx, INC. | $142.35 | 2023 | Barostim Neo System |
| Agepha Pharma Fz LLC | $135.44 | 2025 | Lodoco |
| Amgen INC. | $129.97 | 2021-2023 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $123.12 | 2023 | |
| Edwards Lifesciences Corporation | $118.37 | 2022 | |
| Novartis Pharmaceuticals Corporation | $28.51 | 2022 | |
| Impulse Dynamics (USA) INC. | $27.79 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Knecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.